Featured Research

from universities, journals, and other organizations

Chronic hepatitis C patients who achieve an early viral response can be successfully treated within 6 months

Date:
April 16, 2010
Source:
European Association for the Study of the Liver
Summary:
Twenty-four weeks of treatment could be sufficient to cure between 93 and 100 percent of treatment-naive chronic hepatitis C virus (HCV) genotype 1 (G1) infected patients if they have a fast antiviral response to telaprevir with peginterferon and ribavirin , according to new research.

Twenty-four weeks of treatment could be sufficient to cure between 93 and 100% of treatment-naοve chronic hepatitis C virus (HCV) genotype 1 (G1) infected patients if they have a fast antiviral response to Telaprevir (TVR) with Peginterferon (PEG-IFN) and Ribavirin (RBV), according to new research presented at the International Liver Congress™ 2010, the Annual Meeting of the European Association for the Study of the Liver in Vienna, Austria.

Worldwide, approximately 170 million people are chronically infected with the hepatitis C virus . Since no vaccination is available, effective drug treatment is required to slow down or stop the virus from replicating to help prevent progressive liver damage, cirrhosis, liver failure and liver cancer -- one of the top three causes of cancer death in men, and a major cause of cancer death in women .

Professor Mark Thursz, EASL Vice-Secretary said: "This trial is really helpful as it shows that patients with a good early virological response only need 24 weeks of treatment and that a twice daily dose of Telaprevir is just as effective as three times a day. Although the number of patients in this study was relatively small and should therefore be treated with caution, I expect such findings will make an important contribution in terms of patients' adherence to their therapy and overall treatment outcomes. This will ultimately impact on their overall quality of life."

161 patients from centres throughout Europe and the United States were enrolled in this phase II trial and randomised to receive 12 weeks of TVR at different doses and intervals, in addition to either PEG-IFN-alfa-2a or alpha-2b plus 800-1200mg/day RBV. After 12 weeks, patients received additional PEG-IFN and RBV based on treatment responses -- an additional 12 weeks if HCV RNA was undetectable from week four to week 20, or an additional 36 weeks otherwise.

Interestingly, of the 68% (range across all study arms 56-75%) of patients that qualified to receive only 24 weeks of treatment, between 93 and 100% of the group achieved a Sustained Virologic Response (SVR, when the virus is no longer detected in the blood even after stopping the treatment and considered as a cure for hepatitis C) -- an effect that was observed regardless of the type of PEG-IFN or TVR dosing schedule. Researchers also found that a high SVR was observed in the 18% of patients (range across all study arms 10-24%) that received TVR, PEG-IFN and RBV treatment for 48 weeks.

Overall, within the study period, 14% of patients discontinued treatment before week 24 for reasons including virological failure and adverse events (AE). Between study groups, AE incidence was reported as being comparable and discontinuations of all therapy due to AEs (most frequently reported included rash and anaemia) were recorded at 8% with the majority occurring before week 24.


Story Source:

The above story is based on materials provided by European Association for the Study of the Liver. Note: Materials may be edited for content and length.


Cite This Page:

European Association for the Study of the Liver. "Chronic hepatitis C patients who achieve an early viral response can be successfully treated within 6 months." ScienceDaily. ScienceDaily, 16 April 2010. <www.sciencedaily.com/releases/2010/04/100416144539.htm>.
European Association for the Study of the Liver. (2010, April 16). Chronic hepatitis C patients who achieve an early viral response can be successfully treated within 6 months. ScienceDaily. Retrieved October 20, 2014 from www.sciencedaily.com/releases/2010/04/100416144539.htm
European Association for the Study of the Liver. "Chronic hepatitis C patients who achieve an early viral response can be successfully treated within 6 months." ScienceDaily. www.sciencedaily.com/releases/2010/04/100416144539.htm (accessed October 20, 2014).

Share This



More Health & Medicine News

Monday, October 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Microneedle Patch Promises Painless Pricks

Microneedle Patch Promises Painless Pricks

Reuters - Innovations Video Online (Oct. 18, 2014) — Researchers at The National University of Singapore have invented a new microneedle patch that could offer a faster and less painful delivery of drugs such as insulin and painkillers. Video provided by Reuters
Powered by NewsLook.com
Raw: Nurse Nina Pham Arrives in Maryland

Raw: Nurse Nina Pham Arrives in Maryland

AP (Oct. 17, 2014) — The first nurse to be diagnosed with Ebola at a Dallas hospital walked down the stairs of an executive jet into an ambulance at an airport in Frederick, Maryland, on Thursday. Pham will be treated at the National Institutes of Health. (Oct. 16) Video provided by AP
Powered by NewsLook.com
Raw: Cruise Ship Returns to US Over Ebola Fears

Raw: Cruise Ship Returns to US Over Ebola Fears

AP (Oct. 17, 2014) — A Caribbean cruise ship carrying a Dallas health care worker who is being monitored for signs of the Ebola virus is heading back to Texas, US, after being refused permission to dock in Cozumel, Mexico. (Oct. 17) Video provided by AP
Powered by NewsLook.com
Spanish Govt: Four Suspected Ebola Cases in Spain Test Negative

Spanish Govt: Four Suspected Ebola Cases in Spain Test Negative

AFP (Oct. 17, 2014) — All four suspected Ebola cases admitted to hospitals in Spain on Thursday have tested negative for the deadly virus in a first round of tests, the government said Friday. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins